# The Utility of MRI Scoring to Predict Neurodevelopmental Outcomes in Survivors of Twin-to-Twin Transfusion Syndrome

> **NCT02249624** · — · COMPLETED · sponsor: **Catherine Cibulskis, MD** · enrollment: 51 (actual)

## Conditions studied

- Fetofetal Transfusion

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02249624
- **Lead sponsor:** Catherine Cibulskis, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2020-09-30
- **Final completion:** 2024-05-30
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2024-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02249624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02249624, "The Utility of MRI Scoring to Predict Neurodevelopmental Outcomes in Survivors of Twin-to-Twin Transfusion Syndrome". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02249624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*